Wall Street analysts predict that Molina Healthcare, Inc. (NYSE:MOH) will report $2.62 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Molina Healthcare’s earnings, with estimates ranging from $2.55 to $2.70. Molina Healthcare reported earnings per share of $3.88 in the same quarter last year, which would indicate a negative year-over-year growth rate of 32.5%. The company is expected to report its next quarterly earnings results after the market closes on Monday, February 10th.
According to Zacks, analysts expect that Molina Healthcare will report full year earnings of $11.58 per share for the current fiscal year, with EPS estimates ranging from $11.50 to $11.70. For the next financial year, analysts anticipate that the firm will post earnings of $11.83 per share, with EPS estimates ranging from $11.49 to $12.11. Zacks’ EPS averages are a mean average based on a survey of research firms that cover Molina Healthcare.
Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $2.80 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.70 by $0.10. The business had revenue of $4.24 billion during the quarter, compared to the consensus estimate of $4.15 billion. Molina Healthcare had a net margin of 4.47% and a return on equity of 49.14%. The firm’s quarterly revenue was down 9.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.97 EPS.
Several equities analysts have recently issued reports on the company. ValuEngine lowered Molina Healthcare from a “hold” rating to a “sell” rating in a report on Saturday, January 4th. Deutsche Bank lifted their price target on Molina Healthcare from $145.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, January 7th. JPMorgan Chase & Co. boosted their price objective on Molina Healthcare from $150.00 to $152.00 and gave the stock an “overweight” rating in a research report on Friday, December 20th. Finally, Jefferies Financial Group downgraded Molina Healthcare from a “buy” rating to a “hold” rating and reduced their price objective for the company from $133.00 to $120.00 in a research note on Wednesday, October 30th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the stock. Molina Healthcare presently has an average rating of “Hold” and a consensus target price of $156.67.
In other news, Director Dale B. Wolf sold 3,500 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $135.51, for a total transaction of $474,285.00. Following the completion of the sale, the director now owns 8,461 shares in the company, valued at approximately $1,146,550.11. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Ronna Romney sold 375 shares of Molina Healthcare stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $121.97, for a total transaction of $45,738.75. The disclosure for this sale can be found here. Insiders own 0.77% of the company’s stock.
A number of institutional investors have recently bought and sold shares of the stock. Amundi Pioneer Asset Management Inc. grew its holdings in Molina Healthcare by 315.6% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 49,874 shares of the company’s stock valued at $7,080,000 after purchasing an additional 37,873 shares during the period. Parametric Portfolio Associates LLC grew its stake in shares of Molina Healthcare by 16.7% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 106,000 shares of the company’s stock worth $15,173,000 after acquiring an additional 15,171 shares during the period. Balyasny Asset Management LLC grew its stake in shares of Molina Healthcare by 84.2% during the 2nd quarter. Balyasny Asset Management LLC now owns 9,408 shares of the company’s stock worth $1,347,000 after acquiring an additional 4,300 shares during the period. Marshall Wace North America L.P. purchased a new stake in Molina Healthcare in the 2nd quarter worth about $15,626,000. Finally, Paloma Partners Management Co increased its holdings in Molina Healthcare by 65.0% in the 2nd quarter. Paloma Partners Management Co now owns 10,289 shares of the company’s stock worth $1,473,000 after acquiring an additional 4,053 shares during the last quarter. Institutional investors and hedge funds own 96.39% of the company’s stock.
Shares of NYSE MOH traded down $4.04 during midday trading on Friday, reaching $136.82. The company’s stock had a trading volume of 523,800 shares, compared to its average volume of 593,483. The stock has a market capitalization of $8.27 billion, a P/E ratio of 12.35, a PEG ratio of 1.17 and a beta of 1.15. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.78 and a quick ratio of 1.78. The firm has a 50 day moving average price of $135.18 and a 200-day moving average price of $129.20. Molina Healthcare has a 12-month low of $106.50 and a 12-month high of $159.00.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Read More: What is a portfolio manager?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.